Found: 22
Select item for more details and to access through your institution.
Tolerance of radiotherapy with concomitant glofitamab in diffuse large B cell lymphoma: a case report.
- Published in:
- Strahlentherapie und Onkologie, 2024, v. 200, n. 11, p. 983, doi. 10.1007/s00066-024-02256-0
- By:
- Publication type:
- Article
Severe bleeding events among critically ill patients with haematological malignancies.
- Published in:
- Annals of Intensive Care, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13613-024-01383-2
- By:
- Publication type:
- Article
Ferroptose, métabolisme lipidique, C/EBPα et résistance thérapeutique dans les leucémies aiguës myéloïdes.
- Published in:
- Médecine Sciences, 2023, v. 39, n. 12, p. 917, doi. 10.1051/medsci/2023171
- By:
- Publication type:
- Article
Ferroptose et cancer: Implications physiopathologiques et thérapeutiques.
- Published in:
- Médecine Sciences, 2021, v. 37, n. 8/9, p. 726, doi. 10.1051/medsci/2021108
- By:
- Publication type:
- Article
Clinico‐biological features, treatment and prognosis of primary myeloid sarcoma: A French retrospective multi‐centric observational study.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 6, p. e50, doi. 10.1111/bjh.18961
- By:
- Publication type:
- Article
Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patients.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 1, p. 37, doi. 10.1111/bjh.14387
- By:
- Publication type:
- Article
A case of BK virus nephropathy without hemorrhagic cystitis after hematopoietic stem cell transplantation.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM).
- Published in:
- Cancers, 2023, v. 15, n. 16, p. 4028, doi. 10.3390/cancers15164028
- By:
- Publication type:
- Article
Multiple Myeloma in Patients over 80: A Real World Retrospective Study of First Line Conservative Approach with Bortezomib Dexamethasone Doublet Therapy and Mini-Review of Literature.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4741, doi. 10.3390/cancers14194741
- By:
- Publication type:
- Article
AMP-Activated Protein Kinase Contributes to Apoptosis Induced by the Bcl-2 Inhibitor Venetoclax in Acute Myeloid Leukemia.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 5966, doi. 10.3390/cancers13235966
- By:
- Publication type:
- Article
Pairing MCL‐1 inhibition with venetoclax improves therapeutic efficiency of BH3‐mimetics in AML.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 5, p. 588, doi. 10.1111/ejh.13492
- By:
- Publication type:
- Article
When refeeding is not enough: severe and prolonged pancytopenia in an adolescent with anorexia nervosa.
- Published in:
- Eating & Weight Disorders, 2022, v. 27, n. 8, p. 3797, doi. 10.1007/s40519-022-01478-4
- By:
- Publication type:
- Article
Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 11, p. 2377, doi. 10.3390/v14112377
- By:
- Publication type:
- Article
Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patients.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00718-1
- By:
- Publication type:
- Article
Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00405
- By:
- Publication type:
- Article
Accuracy and safety of 101 consecutives neurosurgical procedures for newly diagnosed central nervous system lymphomas: a single-institution experience.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 159, n. 2, p. 347, doi. 10.1007/s11060-022-04069-6
- By:
- Publication type:
- Article
Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 757, p. 1, doi. 10.1126/scitranslmed.adk1731
- By:
- Publication type:
- Article
Pharmaceutical cancer care for haematology patients on oral anticancer drugs: Findings from an economic, clinical and organisational analysis.
- Published in:
- European Journal of Cancer Care, 2022, v. 31, n. 6, p. 1, doi. 10.1111/ecc.13753
- By:
- Publication type:
- Article
Antileukemic activity of the VPS34-IN1 inhibitor in acute myeloid leukemia.
- Published in:
- Oncogenesis, 2020, v. 9, n. 10, p. 1, doi. 10.1038/s41389-020-00278-8
- By:
- Publication type:
- Article
From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.586530
- By:
- Publication type:
- Article
Establishing assay-specific 97.5th percentile upper reference limit for serum D-2-hydroxyglutarate for the management of patients with acute myeloid leukemia.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor